- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
Helmsley Grant to UFDI to Study Immune Repertoire in T1D
University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T […]
Join Our Mission
The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”
ATG Preserves β-Cell Function in Clinical Trial
The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).
What’s your GRS?
The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk
Our Research Focus
Our laboratory aims to harness the power of naturally occurring regulatory T cells to correct unwanted immune responses that deliver a cure for type 1 diabetes.
Our Staff
From undergraduate students to post-doctoral fellows – every set of hands is important.
